GMP – Page 18 – Pharma.Tips

Stability data gaps during inspection preparation – CAPA expectations for PQ approval

Effective Solutions for Stability Data Gaps During Inspection Readiness for PQ Approval During the preparation for inspections related to WHO Prequalification (PQ) approval, the identification of stability data gaps can…

CAPA effectiveness doubted during WHO PQ assessment – preventing PQ suspension

Strategies to Ensure CAPA Effectiveness and Prevent Suspension During WHO PQ Assessments Manufacturers aiming for WHO Prequalification (PQ) face strict scrutiny that often casts doubt on the effectiveness of Corrective…

Extended cleaning duration during equipment changeover – validated efficiency improvement

“`html Optimizing Extended Cleaning Duration During Equipment Changeover for Efficiency Improvement In the pharmaceutical manufacturing sector, extended cleaning durations during equipment changeover can significantly impact productivity, efficiency, and compliance with…

PQ dossier deficiency during inspection preparation – PQ assessment risk and mitigation

Addressing PQ Dossier Deficiencies for Successful Inspection Preparation In today’s pharmaceutical environment, the ability to prepare comprehensively for inspections is paramount. A deficiency in the PQ dossier can compromise not…

Manufacturing site not PQ-ready during inspection preparation – preventing PQ suspension

Ensuring Manufacturing Sites Are Prepared for PQ Inspections: A Playbook In the pharmaceutical industry, the inability of a manufacturing site to meet prequalification (PQ) standards prior to inspection can lead…

Manufacturing site not PQ-ready during dossier submission – how to defend manufacturing readiness

Defending Manufacturing Readiness When Your Site Isn’t PQ-Ready During Dossier Submission Pharmaceutical manufacturers often face stringent regulatory requirements, particularly during WHO Prequalification (PQ) submissions. An alarming finding can be a…

Manual cleaning variability during multi-product campaigns – inspection-ready cleaning optimization

Improving Manual Cleaning Consistency During Multi-Product Campaigns In the pharmaceutical manufacturing environment, the variability in manual cleaning processes during multi-product campaigns can lead to contamination risks, potential regulatory non-compliance, and…

CAPA effectiveness doubted during WHO PQ assessment – documentation gaps reviewers flag

Ensuring CAPA Effectiveness During WHO Prequalification Assessments In the pharmaceutical industry, maintaining high standards of compliance is critical, especially during WHO Prequalification (PQ) assessments. Questions surrounding the effectiveness of Corrective…

Deviation history questioned during inspection preparation – how to defend manufacturing readiness

Preparing for Inspections When Your Deviation History is Under Scrutiny In the ever-evolving landscape of pharmaceutical manufacturing, the scrutiny of deviation history during inspections poses a substantial challenge. Regulatory authorities…

API change not reported during WHO PQ assessment – preventing PQ suspension

Preventing Suspension from WHO PQ Due to Unreported API Changes In today’s complex pharmaceutical landscape, companies face the daunting challenge of maintaining compliance with regulatory bodies while managing changes in…

Equipment downtime due to cleaning during multi-product campaigns – validated efficiency improvement

Mitigating Equipment Downtime During Cleaning in Multi-Product Campaigns In the pharmaceutical manufacturing landscape, especially in facilities engaged in multi-product campaigns, equipment downtime due to cleaning can be a significant bottleneck.…

Deviation history questioned during requalification – how to defend manufacturing readiness

Defending Manufacturing Readiness Against Deviation History Challenges During Requalification In the pharmaceutical industry, maintaining rigorous adherence to Good Manufacturing Practices (GMP) is crucial for ensuring compliance with regulatory requirements. However,…